Filing Details
- Accession Number:
- 0000899243-16-017456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-04 19:23:32
- Reporting Period:
- 2016-03-31
- Filing Date:
- 2016-04-04
- Accepted Time:
- 2016-04-04 19:23:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609809 | Seres Therapeutics Inc. | MCRB | Pharmaceutical Preparations (2834) | 274326290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643734 | D. Eric Shaff | C/O Seres Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Cfo And Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-31 | 7,663 | $7.79 | 7,663 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-03-31 | 1,095 | $25.13 | 6,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-31 | 6,568 | $26.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option(right to buy) | Disposition | 2016-03-31 | 7,663 | $0.00 | 7,663 | $7.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 249,556 | 2024-12-08 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- The option vested as to 25% of the shares subject to the option on November 17, 2015, and has vested or will vest as to an additional 6.25% of the total number of shares subject to the option upon the completion of each three consecutive months of service thereafter.
Billionaire Hedge Funds
